1. Home
  2. QFIN vs BHVN Comparison

QFIN vs BHVN Comparison

Compare QFIN & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Qifu Technology Inc.

QFIN

Qifu Technology Inc.

N/A

Current Price

$13.20

Market Cap

1.9B

Sector

Finance

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$8.40

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QFIN
BHVN
Founded
2016
2013
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
QFIN
BHVN
Price
$13.20
$8.40
Analyst Decision
Strong Buy
Buy
Analyst Count
3
14
Target Price
$32.37
$28.85
AVG Volume (30 Days)
1.4M
1.9M
Earning Date
03-17-2026
03-02-2026
Dividend Yield
11.74%
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.68
$7.48
52 Week High
$48.94
$31.18

Technical Indicators

Market Signals
Indicator
QFIN
BHVN
Relative Strength Index (RSI) 35.91 26.55
Support Level N/A $7.48
Resistance Level $15.46 $15.66
Average True Range (ATR) 0.54 0.61
MACD -0.04 -0.14
Stochastic Oscillator 22.86 4.37

Price Performance

Historical Comparison
QFIN
BHVN

About QFIN Qifu Technology Inc.

Qfin Holdings Inc Formerly Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: